Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.4.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.4.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.4.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-21779.1China
BN.1.4.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16669.7China
BN.1.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.58EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.58ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.58ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.58EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.58EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XAY.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XAY.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XAY.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAY.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XAY.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.71EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.71ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.71ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.71EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.71EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.3.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.3.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.3.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.2.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.2.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.2.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.25EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used